Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

Ahead Health AG

History from 26 Aug 2024

UID
CHE-213.692.684
Legal form
AG
Canton
ZH
Founded
26 Aug 2024
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 199k
50k99k149k199k10 Nov 2025 · CHF 170k28 Apr 2026 · CHF 199kRound announced 29 Jul 2026Round announced 13 Jan 20262026
  • shares
  • Vorzugsaktien Seed
  • round announced

Record

  1. Company formed

    Founded 26 Aug 2024

    SHAB HR01-1006116727 ↗
  2. Capital increase

    Likely financing · possible confirmation

    Paid in cash and by other means

    Nominal capital
    100’000 → 170’151.13
    Shares
    10’000’000 → 17’015’113
    New shares, % of post-step shares
    41.2% (7’015’113 new)
    Share classes
    13’282’500 × CHF 0.01 · 3’732’613 × CHF 0.01 Vorzugsaktien Seed

    Aktienkapital neu: CHF 170'151.13 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 120'151.13 [bisher: CHF 50'000.00]. Aktien neu: 13'282'500 Namenaktien zu CHF 0.01 und 3'732'613 Namenaktien zu CHF 0.01 (Vorzugsaktien Seed) [bisher: 10'000'000 Namenaktien zu CHF 0.01]. Die Gesellschaft hat mit Beschluss vom 28.10.2025 ein Kapitalband gemäss näherer Umschreibung in den Statuten beschlossen.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5
    • A new class of preferred shares was created.+1.5

    Classifier score 0.85 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006479540 ↗
  3. Capital band adopted

    SHAB HR02-1006479540 ↗
  4. Round announced

    possible match · low match confidence

    Announcement ↗
  5. Capital increase

    Confirmed round · missed by classifier

    Issued from conditional capital

    Nominal capital
    170’151.13 → 198’516.23
    Shares
    17’015’113 → 19’851’623
    New shares, % of post-step shares
    14.3% (2’836’510 new)
    Share classes
    13’789’875 × CHF 0.01 · 6’061’748 × CHF 0.01 Vorzugsaktien Seed

    Aktienkapital neu: CHF 198'516.23 [bisher: CHF 170'151.13]. Liberierung Aktienkapital neu: CHF 148'516.23 [bisher: CHF 120'151.13]. Aktien neu: 13'789'875 Namenaktien zu CHF 0.01 und 6'061'748 Namenaktien zu CHF 0.01 (Vorzugsaktien Seed) [bisher: 13'282'500 Namenaktien zu CHF 0.01 und 3'732'613 Namenaktien zu CHF 0.01 (Vorzugsaktien Seed)]. [bisher: Die Gesellschaft hat mit Beschluss vom 28.10.2025 ein Kapitalband gemäss näherer Umschreibung in den Statuten beschlossen.]

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5
    • Shares issued out of conditional capital, as when options are exercised.−1.0

    Classifier score 0.15 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006636170 ↗
  6. Capital band adopted

    SHAB HR02-1006636170 ↗
  7. Round announced

    matched to a capital increase · high match confidence

    Announcement ↗

Published by 8 Oct 2026